Ishare Nq Biotch ETF (IBB) 294.15 $IBB Watch for iShares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ishare Nq Biotch ETF (IBB) 294.15 $IBB

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 1.41% Yesterday
Comtex SmarTrend(R) - 1 hr 18 mins ago
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $289.87 to a high of $296.84. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $289.77 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 294.15 (+4.71)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.41% Rise
Comtex SmarTrend(R) - 1 hr 19 mins ago
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $289.87 to a high of $296.84. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $289.77 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 294.15 (+4.71)

Analyzing a Politically Sensitive Group of ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Jul 29, 9:48AM CDT
Few corners of the market have been endured presidential election year volatility on par with biotechnology stocks and exchange traded funds such as the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB). Actually, political headwinds faced by IBB and...
IBB: 294.15 (+4.71)

Analysts Forecast 28% Upside For The Holdings of IBB
ETFChannel.com - Thu Jul 28, 6:31AM CDT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst...
IBB: 294.15 (+4.71)

iShares Nasdaq Biotechnology Index Rises 1.45% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jul 27, 1:06PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $280.25 to a high of $284.98. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $282.74 on volume of 613,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 294.15 (+4.71)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 1.45% Gain
Comtex SmarTrend(R) - Wed Jul 27, 1:05PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $280.25 to a high of $284.98. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $282.74 on volume of 613,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 294.15 (+4.71)

Biotech ETFs: Will the Once Hot Group Rebound?
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jul 13, 8:00AM CDT
The struggling biotechnology group and exchange traded funds such as the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, are leaving investors wondering when this once hot corner of the market will...
FBT: 102.70 (+2.44), XBI: 63.64 (+1.57), IBB: 294.15 (+4.71)

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.80%
Comtex SmarTrend(R) - Tue Jun 21, 12:19PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $252.86 to a high of $259.50. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $256.34 on volume of 785,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 294.15 (+4.71)

Vista Partners Publishes June 2016 Macroeconomic & Investment Newsletter
Marketwire Canada - Tue Jun 21, 8:01AM CDT
Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Big Data, Biotechnology, Fintech, Healthcare, IoT, SaaS, Sports, WearableTech & More
IBB: 294.15 (+4.71), IMNP: 0.38 (-0.02)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 1.20% Sell Off
Comtex SmarTrend(R) - Fri Jun 17, 12:13PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $257.55 to a high of $262.99. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $258.19 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 294.15 (+4.71)

After Yesterday's Decline of 1.11%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jun 13, 12:09PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $264.04 to a high of $269.98. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $266.20 on volume of 893,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 294.15 (+4.71)

The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology, Biogen, Alexion Pharma, BioMarin Pharma and Regeneron
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:30AM CDT
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology, Biogen, Alexion Pharma, BioMarin Pharma and Regeneron
BIIB: 302.77 (+12.84), BMRN: 100.10 (+0.68), ALXN: 133.02 (+4.42), IBB: 294.15 (+4.71), REGN: 433.54 (+8.42)

4 Stocks That Crushed the Biotechnology ETF (IBB) This Week
Eric Dutram - Zacks Investment Research - Fri Jun 10, 12:15PM CDT
It was a rough week for the biotechnology ETF (IBB). Which stocks pushed this key sector fund lower for the week?
BIIB: 302.77 (+12.84), BMRN: 100.10 (+0.68), SRPT: 25.81 (+0.53), ALXN: 133.02 (+4.42), IBB: 294.15 (+4.71), REGN: 433.54 (+8.42)

Watch for iShares Nasdaq Biotechnology Index to Potentially Rebound After Falling 2.31% Yesterday
Comtex SmarTrend(R) - Tue Jun 07, 11:58AM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.30 to a high of $282.65. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $277.93 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 294.15 (+4.71)

A Catalyst for Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Mon Jun 06, 7:00AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, is up 9.2% over the past month. Performances for some rival biotech ETFs have been even better and that may be setting the stage for once beloved...
FBT: 102.70 (+2.44), XBI: 63.64 (+1.57), IBB: 294.15 (+4.71)

Trying to Believe in Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Jun 03, 7:00AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs are vexing investors this year. Just when turnarounds for these funds look legitimate, they tumble again, prompting investors...
FBT: 102.70 (+2.44), XBI: 63.64 (+1.57), IBB: 294.15 (+4.71)

A Fed Focused on Legacy?
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Jun 03, 7:00AM CDT
Note: This article appears on the ETFtrends.com Strategist Channel By Dr. Vito Sciaraffia Federal Reserve Chairperson Paul Volker is remembered for taming the rampant inflation of the late 1970s-early 1980s. Present Chairperson Janet Yellen and her...
FBT: 102.70 (+2.44), XBI: 63.64 (+1.57), IBB: 294.15 (+4.71)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 122

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Caladan Partners with Anchorage for Stronger Trading

Updated Category News Views 35

Caladan and Anchorage Unite for Asset Growth Man, partnerships might just be the secret sauce we never know we need until it’s on our plate. It's a fresh day in digital trading, and Caladan just shook things up by teaming up with Anchorage Digital, bolstering their trading and settlement capabilities to satisfy the big players. If there's one thing that's hot as a...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 109

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
NestWorks' C500: Shaking Up CNC at Formnext 2026

Updated Category News Views 86

NestWorks C500: A Game Changer for Makers Folks, gather 'round, because NestWorks is turning heads with their C500 desktop CNC machine. As it lands firmly on TIME’s Best Inventions of 2026 list, this ain't just another gadget adorning a workshop—all eyes are on it at Formnext 2026. From November 17–20, Frankfurt is the stage where NestWorks plans to showcase how...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 459

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 165

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Dawson Struggles With Q3 Losses Despite Growth Prospects

Updated Category News Views 25

Profit and loss dance around like a jittery stock, and Dawson Geophysical is feeling the heat this third quarter. Numbers are in, and we’re seeing a net loss of $5.2 million, translating to $0.17 per share—ouch. Not to mention a negative Adjusted EBITDA of $2 million. Compared to last year's hopes, that's a serious belly flop. Revenue Down, Hopes Up In a fetching...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 94

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Engrain's Geospatial Innovation Pushes Property Mapping Forward

Updated Category News Views 21

Pushing the Boundaries of Property Mapping How far can you expand the boundaries of property mapping tech? Well, Engrain seems hell-bent on finding out by cranking their innovations up a notch. The Denver-based stalwart in interactive mapping is rolling out some mind-boggling enhancements that could redefine how the multifamily housing sector operates. This isn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Future of Super Abrasives in Precision Engineering Markets

Updated Category News Views 96

Projected Growth of the Super Abrasives Market The global super abrasives market is on an exceptional growth trajectory, aiming to surpass a valuation of US$ 11.0 billion by 2032 from US$ 7.0 billion in 2023. This impressive growth, forecasted at an estimated CAGR of 6.5% from 2024 to 2032, reflects the diverse opportunities that lie ahead. Industry Drivers and...

Continue Reading
PSE&G Gains Top Spot in JD Power Rankings: What's Behind the Success?

Updated Category News Views 236

PSE&G Climbs To Number One Spot: What's Changed? Public Service Electric & Gas (PSE&G), New Jersey's largest utility, just snagged the top spot for business electric customer satisfaction in the East, according to JD Power's latest study. This is an upgrade from their second place showing in 2025. But how did they leapfrog their competition to reach the pinnacle? The...

Continue Reading
Hilbert Group Enhances Portfolio with Investment in CCD Token

Updated Category News Views 160

Hilbert Group Broadens Its Horizon with Strategic Investment Hilbert Group, a renowned global digital asset investment firm, is making waves in the blockchain space with its latest strategic long-term investment in CCD, the native token of Concordium, a cutting-edge PayFi blockchain designed for institutional-grade payments. A Landmark Move Beyond Bitcoin and Ethereum...

Continue Reading
Explore the Dynamic Features of the 2026 Ford Escape Now

Updated Category News Views 272

Discover the Exciting Evolution of the 2026 Ford Escape The all-new 2026 Ford Escape brings significant improvements in design, technology, and performance that will surely captivate new car buyers. Akins Ford, a premier Ford dealership near Atlanta, is excited to offer an in-depth look at what makes this compact SUV a standout choice for drivers. Key Design Enhancements...

Continue Reading
Forestar Group Navigates Challenges as Stock Hits New Low

Updated Category News Views 117

Forestar Group’s Stock Hits a 52-Week Low Forestar Group Inc. (NYSE: FOR) is experiencing a tough time in the current market environment. The company's shares have recently fallen to a 52-week low of $25.27. This decline highlights the struggles faced by the real estate and land development sector over the past year, contributing to a substantial 24.6% decrease in their...

Continue Reading